Quantcast

Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis.

Research paper by Atsushi A Watanabe, Masayoshi M Miyajima, Taijiro T Mishina, Junji J Nakazawa, Ryo R Harada, Nobuyoshi N Kawaharada, Tetsuya T Higami

Indexed on: 29 Nov '12Published on: 29 Nov '12Published in: General Thoracic and Cardiovascular Surgery



Abstract

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. IPF is associated with an increased risk of lung cancer, and lung cancer patients with IPF undergoing pulmonary resection for non-small cell lung cancer have increased postoperative morbidity and mortality. Especially, postoperative acute exacerbation of IPF (AEIPF) causes fatal status and long-term outcomes are worse than for patients without IPF, although certain subgroups have a good long-term outcome. A comprehensive review of the current literature pertaining to AEIPF and the late phase outcome after the context of a surgical intervention was performed.